(FILES) Dario Amodei, co-founder and CEO of Anthropic, an artificial intelligence safety and research company, takes part in a debate at the Vivatech technology start-ups and innovation fair, at the Porte de Versailles exhibition center in Paris, on May 22, 2024. The surge in artificial intelligence and the heated debate around its risks have made Anthropic CEO Dario Amodei the most visible tech leader -- though the 43-year-old remains an enigma. The San Francisco native built in just five years a company that could be valued at 2 trillion dollars when it goes public this fall. (Photo by JULIEN DE ROSA / AFP via Getty Images)

People take part in a protest against the US tech company Palantir outside their UK headquarters in central London on October 1, 2026, to urge the British government to use a break clause that would prevent a contract between the AI giant and the National Health Service (NHS) being renewed beyond March 2027. The UK government is facing mounting pressure to end a £330-million (438 million USD) contract between the NHS and Palantir, as doctors, lawmakers and campaigners warn of ethical risks. (Photo by Henry NICHOLLS / AFP via Getty Images)

People take part in a protest against the US tech company Palantir outside their UK headquarters in central London on October 1, 2026, to urge the British government to use a break clause that would prevent a contract between the AI giant and the National Health Service (NHS) being renewed beyond March 2027. The UK government is facing mounting pressure to end a £330-million (438 million USD) contract between the NHS and Palantir, as doctors, lawmakers and campaigners warn of ethical risks. (Photo by Henry NICHOLLS / AFP via Getty Images)

A person takes part in a counter protest supporting the US tech company Palantir outside their UK headquarters in central London on October 1, 2026. The UK government is facing mounting pressure to end a £330-million (438 million USD) contract between the NHS and Palantir, as doctors, lawmakers and campaigners warn of ethical risks. (Photo by Henry NICHOLLS / AFP via Getty Images)

People take part in a protest against the US tech company Palantir outside their UK headquarters in central London on October 1, 2026, to urge the British government to use a break clause that would prevent a contract between the AI giant and the National Health Service (NHS) being renewed beyond March 2027. The UK government is facing mounting pressure to end a £330-million (438 million USD) contract between the NHS and Palantir, as doctors, lawmakers and campaigners warn of ethical risks. (Photo by Henry NICHOLLS / AFP via Getty Images)

A police officer shouts as people take part in a counter protest supporting the US tech company Palantir outside their UK headquarters in central London on October 1, 2026. The UK government is facing mounting pressure to end a £330-million (438 million USD) contract between the NHS and Palantir, as doctors, lawmakers and campaigners warn of ethical risks. (Photo by Henry NICHOLLS / AFP via Getty Images)

People take part in a protest against for and against US tech company Palantir outside their UK headquarters in central London on October 1, 2026, some urging the British government to use a break clause that would prevent a contract between the AI giant and the National Health Service (NHS) being renewed beyond March 2027. The UK government is facing mounting pressure to end a £330-million (438 million USD) contract between the NHS and Palantir, as doctors, lawmakers and campaigners warn of ethical risks. (Photo by Henry NICHOLLS / AFP via Getty Images)

People take part in a counter protest supporting the US tech company Palantir outside their UK headquarters in central London on October 1, 2026. The UK government is facing mounting pressure to end a £330-million (438 million USD) contract between the NHS and Palantir, as doctors, lawmakers and campaigners warn of ethical risks. (Photo by Henry NICHOLLS / AFP via Getty Images)